KAYSEN DAVID B 4
4 · Sun BioPharma, Inc. · Filed Mar 1, 2018
Insider Transaction Report
Form 4
KAYSEN DAVID B
President and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-27+50,000→ 50,000 totalExercise: $8.10From: 2018-02-27Exp: 2028-02-27→ Common Stock (50,000 underlying)